ArticleBMC endocrine disorders2025
Clinical, radiological, and pathological characteristics and long-term outcomes of silent corticotroph adenomas: a retrospective study.
Article in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A late awakening: delayed functional transformation of a silent corticotroph adenoma into Cushing disease.JCEM case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSilent corticotroph adenomas (SCAs), a subtype of non-functioning pituitary adenomas (NFPAs), exhibit aggressive biological behaviour despite the absence of clinical hormone hypersecretion. This study aimed to identify preoperative predictors of SCAs and evaluate prognostic factors for postoperative recurrence in both NFPAs and SCAs.
methodsWe retrospectively analysed 192 patients with NFPAs who underwent transsphenoidal surgery between 2014 and 2019. Clinical presentation, imaging findings, pathological characteristics, surgical outcomes, and recurrence data were compared. Logistic regression and receiver operating characteristic analyses were used to identify predictors of SCAs. Recurrence-free survival was assessed using Kaplan-Meier analysis, and Cox regression was applied to determine independent prognostic factors.
resultsSCAs were more frequent in female patients and were associated with visual impairment, multiple microcysts, and sellar floor invasion (all p < 0.01). Logistic regression identified these factors as independent predictors, with an area under the curve (AUC) of 0.802. During a median follow-up of 53.5 months, the recurrence rate was significantly higher in the SCA group than in the non-SCA group (40.9% vs. 19.6%; p = 0.004). In NFPAs, Knosp grade ≥ 3, Ki-67 ≥ 3%, and subtotal resection (STR) were independent risk factors for recurrence. In SCAs, only Ki-67 ≥ 3% (hazard ratio [HR] = 5.122; p = 0.004) and STR (HR = 3.273; p = 0.018) remained significant.
conclusionSCAs are a biologically aggressive subtype of NFPA with distinct clinicopathological features. Reliable preoperative indicators and recognition of recurrence risk factors is essential to guide early diagnosis, close surveillance, and individualised treatment to improve long-term outcomes. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.